by Clinical Neuropsychologist Online | Wednesday, September 9, 2026 | Neuroscience
Nature Neuroscience, Published online: 09 September 2026; doi:10.1038/s41593-026-02432-8van der Valk et al. mapped the cell types that build the human inner ear during early development, identifying a molecular signal that instructs cell specification and using it to...
by Clinical Neuropsychologist Online | Wednesday, September 9, 2026 | Dementia
Abstract INTRODUCTION Adults with Down syndrome (DS) have a higher risk of Alzheimer’s disease (AD). As gut microbiota (GM) alterations have been reported in AD, we investigated their association with cognitive decline and plasma AD biomarkers in DS. METHODS...
by Clinical Neuropsychologist Online | Wednesday, September 9, 2026 | Dementia
Abstract INTRODUCTION Efficient cerebral microhemorrhage (MCH) monitoring is critical for anti-amyloid therapy safety due to amyloid-related imaging abnormalities with hemosiderin deposition (ARIA-H) risk. We developed MCH-Guard, a multimodal machine-learning...
by Clinical Neuropsychologist Online | Wednesday, September 9, 2026 | Dementia
Abstract INTRODUCTION Motoric cognitive risk syndrome (MCR) is a predementia condition that predicts multiple adverse health outcomes. Age-friendly environments (AFE) represent a key strategy for promoting healthy aging and may reduce MCR risk. However, little is...
by Clinical Neuropsychologist Online | Wednesday, September 9, 2026 | Dementia
Abstract BACKGROUND Sleep phenotypes differ in progressive supranuclear palsy (PSP) and Alzheimer’s disease (AD). The human intermediate nucleus (IntN), a putative ventrolateral preoptic analog, promotes non-rapid eye movement (NREM) sleep, but its...
